NEWS
Our Latest News
ARCHIMED buys Cellese, a pioneering developer of growth factors and exosome-based skincare products
ARCHIMED’s NAMSA returns more than a third of investment
October
7,
2021
ARCHIMED backs Xpress Biologics, a leading provider of plasmid DNA for advanced therapy medicinal products
October
5,
2021
ARCHIMED’s NAMSA consolidates leadership in Medical Device Clinical Research, buying Clinlogix
August
2,
2021
368